Cardiac disease in pregnancy and arrhythmias: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 8: | Line 8: | ||
*If there is hemodynamic compromise, the patient can be treated with DC [[cardioversion]]. | *If there is hemodynamic compromise, the patient can be treated with DC [[cardioversion]]. | ||
*A rapid narrow complex rhythm suggestive of [[AV nodal re-entry tachycardia]] ([[AVNRT]]) can be treated emergently with IV [[adenosine]] which has a very short half life. | *A rapid narrow complex rhythm suggestive of [[AV nodal re-entry tachycardia]] ([[AVNRT]]) can be treated emergently with IV [[adenosine]] which has a very short half life. | ||
*Lopressor is a mainstay of prevention of SVT in the setting of pregnancy. [[Atenolol]] and [[propranolol]] should be avoided given the risk of [[intrauterine growth retardation]]. [[Calcium channel blockade]] would be second line therapy. [[Sotalol]] and [[flecainide]] can be used in refractory cases. Ablation can be performed in refractory cases. Given the risk of fetal hypo/hyperthyroidism with amiodarone, this agent is not recommended. | |||
==Anti-arrhythmic Drugs to Avoid During the Pregnancy== | ==Anti-arrhythmic Drugs to Avoid During the Pregnancy== | ||
Revision as of 14:21, 11 October 2012
|
Cardiac disease in pregnancy Microchapters |
|
Diagnosis |
|---|
|
Catheterization: |
|
Treatment |
|
Special Scenarios:
|
|
Cardiac disease in pregnancy and arrhythmias On the Web |
|
American Roentgen Ray Society Images of Cardiac disease in pregnancy and arrhythmias |
|
Directions to Hospitals Treating Cardiac disease in pregnancy |
|
Risk calculators and risk factors for Cardiac disease in pregnancy and arrhythmias |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Although underlying reasons remain unclear, if a woman has a prior history of arrhythmias, the risk of recurrent arrhythmias may increase during pregnancy.[1] [2] [3] Unfortunately drugs that are effective in the management of arrhythmias such as amiodarone can present a hazard to the fetus during pregnancy.
Supraventricular Tachycardias During Pregnancy
- If there is hemodynamic compromise, the patient can be treated with DC cardioversion.
- A rapid narrow complex rhythm suggestive of AV nodal re-entry tachycardia (AVNRT) can be treated emergently with IV adenosine which has a very short half life.
- Lopressor is a mainstay of prevention of SVT in the setting of pregnancy. Atenolol and propranolol should be avoided given the risk of intrauterine growth retardation. Calcium channel blockade would be second line therapy. Sotalol and flecainide can be used in refractory cases. Ablation can be performed in refractory cases. Given the risk of fetal hypo/hyperthyroidism with amiodarone, this agent is not recommended.
Anti-arrhythmic Drugs to Avoid During the Pregnancy
- Significant fetal abnormalities.
- Neonatal hypothyroidism
- Fetal goiter
- Fetal growth retardation
- Propranolol and atenolol[5] [6]:
- Intrauterine growth restriction
- Hypoglycemia in the newborn
Anti-arrhythmic Drugs to Avoid During Lactation
- Secreted in breast milk
- It becomes concentrated in breast milk. Infants receive much larger doses.
- Neonatal bradycardia
- Neonatal hypoglycemia
Related Chapters
References
- ↑ Tawam M, Levine J, Mendelson M, Goldberger J, Dyer A, Kadish A. Effect of pregnancy on paroxysmal supraventricular tachycardia. Am J Cardiol 1993; 72: 838-40.
- ↑ Brodsky M, Doria R, Allen B, Sato D, Thomas G, Sada M. New-onset ventricular tachycardia during pregnancy. Am Heart J 1992; 123: 933-41.
- ↑ Chow T, Galvin J, McGovern B. Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol 1998; 82 (4A): 58I - 62I.
- ↑ 4.0 4.1 4.2 Onuigbo M, Alikhan M. Over-the-counter sympathomimetics: a risk factor for cardiac arrhythmias in pregnancy. South Med J 1998; 91: 1153-5.
- ↑ Eliahou HE, Silverberg DS, Reisin E, Romem I, Mashiach S, Serr DM. Propranolol for the treatment of hypertension in pregnancy. Br J Obstet Gynaecol 1978;85:431-6.
- ↑ Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999; 12:541-7.